Department of Surgery, Division of Thoracic Surgery, Yale University School of Medicine, New Haven, CT.
Department of Surgery, Loma Linda University School of Medicine, Loma Linda, CA.
Ann Surg. 2024 Aug 1;280(2):193-198. doi: 10.1097/SLA.0000000000006281. Epub 2024 Mar 28.
Nearly 75% of newly diagnosed cancer patients in the United States will receive care from a hospital that is accredited by the Commission on Cancer (CoC). To support hospitals in their quality assurance efforts, the CoC maintains a portfolio of quality measures to give hospitals compliance data with select best practices for cancer care. As the CoC quality measures have evolved over recent years, many clinicians may lack awareness of the intent and content of the measure portfolio, as well as the mechanism by which new measures originate.
The CoC quality measures are based on data that hospitals submit to the National Cancer Database, allowing the CoC to track compliance with a subset of consensus best practices. Each year, new measures are designed by diverse teams of specialists in the different treatment modalities for the tumor types covered by the portfolio. These proposed measures are then subjected to a range of vetting, refinement, and prioritization steps before being voted into the portfolio by the Quality Assurance and Data Committee of the CoC. Over the past 4 years, the CoC has worked to renovate not only the portfolio but also the process used to create and launch new measures, revise existing measures, and retire obsolete measures.
In the following overview, we outline the current measure process, highlight important changes to the portfolio, and share opportunities to further increase the impact.
在美国，近 75%的新诊断癌症患者将在由癌症委员会 (CoC) 认证的医院接受治疗。为了支持医院的质量保证工作，CoC 维护了一组合适的质量措施组合，为医院提供了与癌症护理精选最佳实践一致的合规数据。随着 CoC 质量措施近年来的发展，许多临床医生可能缺乏对措施组合的意图和内容的认识，以及新措施产生的机制。
CoC 质量措施基于医院向国家癌症数据库提交的数据，使 CoC 能够跟踪符合共识最佳实践的子集的合规性。每年，涵盖投资组合的肿瘤类型的不同治疗方式的多样化专家团队都会设计新的措施。然后，这些提议的措施会经过一系列的审查、完善和优先级排序步骤，然后由 CoC 的质量保证和数据委员会投票纳入投资组合。在过去的 4 年中，CoC 不仅致力于翻新投资组合，还致力于创建和推出新措施、修订现有措施和淘汰过时措施的过程。
在以下概述中，我们概述了当前的措施流程，突出了投资组合的重要变化，并分享了进一步提高影响力的机会。
